Endocrinology, Vol 129, 1701-1708, Copyright © 1991 by Endocrine Society

ARTICLES

A novel NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine-binding protein (CTBP; 5.1S) in rat liver: a comparison with 4.7S NADPH- dependent CTBP

M Kobayashi, K Hashizume, S Suzuki, K Ichikawa and T Takeda
Department of Geriatrics, Endocrinology, and Metabolism, Shinshu University School of Medicine, Matsumoto, Japan.

A novel NADPH-dependent cytosolic 3,5,3'-triiodo-L-thyronine (T3)- binding protein (CTBP) was purified by sequential fractionation of rat liver cytosol on Q-Sepharose, phenyl-Sepharose, red-Sepharose, and polyacrylamide gel electrophoresis under nondenaturing conditions. The CTBP had a sedimentation coefficient of 5.1S, a Stokes' radius of 35 A, and a calculated mol wt of 76,000. The apparently homogenous protein consisted of a dimer of a polypeptide chain with a mol wt of 38,000 as estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. NADPH increased both the affinity and maximal binding capacity for T3 in the 5.1S CTBP. The maximal activity to bind T3 was obtained by 3.0 x 10(-8) M NADPH. The calculated maximal affinity constant was 2.4 x 10(9) M-1, and the maximal binding capacity was 21,000 pmol T3/mg 5.1S CTBP. The order of affinity of iodothyronine analogs to the 5.1S CTBP was as follows: D-T3 greater than L-T3 greater than L-T4 greater than triiodothyroacetic acid. The optimal pH for T3 binding was 7.2-7.5. Ca2+, Mg2+, and Mn2+ (0.1-10 mM) did not influence T3 binding to CTBP. Zn2+ (1.0 mM), however, inhibited the binding. These results suggested that 5.1S NADPH-dependent CTBP, which is distinct from 4.7S CTBP that had been purified in our laboratory from rat kidney, is present in rat liver.

This article has been cited by other articles:

				S. Suzuki, N. Suzuki, J.-i. Mori, A. Oshima, S. Usami, and K. Hashizume {micro}-Crystallin as an Intracellular 3,5,3'-Triiodothyronine Holder in Vivo Mol. Endocrinol., April 1, 2007; 21(4): 885 - 894. [Abstract] [Full Text] [PDF]

				A Oshima, S Suzuki, Y Takumi, K Hashizume, S Abe, and S Usami CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea. J. Med. Genet., June 1, 2006; 43(6): e25 - e25. [Abstract] [Full Text] [PDF]

				M. Moreno, E. Silvestri, A. Lombardi, T. J. Visser, F. Goglia, and A. Lanni Identification of 3,5-Diiodo-L-Thyronine-Binding Proteins in Rat Liver Cytosol by Photoaffinity Labeling Endocrinology, June 1, 2003; 144(6): 2297 - 2303. [Abstract] [Full Text] [PDF]

				J.-i. Mori, S. Suzuki, M. Kobayashi, T. Inagaki, A. Komatsu, T. Takeda, T. Miyamoto, K. Ichikawa, and K. Hashizume Nicotinamide Adenine Dinucleotide Phosphate-Dependent Cytosolic T3 Binding Protein as a Regulator for T3-Mediated Transactivation Endocrinology, April 1, 2002; 143(4): 1538 - 1544. [Abstract] [Full Text] [PDF]

				K. Yamauchi, J.-i. Nakajima, H. Hayashi, R. Horiuchi, and J. R. Tata Xenopus Cytosolic Thyroid Hormone-binding Protein (xCTBP) Is Aldehyde Dehydrogenase Catalyzing the Formation of Retinoic Acid J. Biol. Chem., March 26, 1999; 274(13): 8460 - 8469. [Abstract] [Full Text] [PDF]

				M.-P. Vié, C. Evrard, J. Osty, A. Breton-Gilet, P. Blanchet, M. Pomérance, P. Rouget, J. Francon, and J.-P. Blondeau Purification, Molecular Cloning, and Functional Expression of the Human Nicodinamide-Adenine Dinucleotide Phosphate-Regulated Thyroid Hormone-Binding Protein Mol. Endocrinol., October 1, 1997; 11(11): 1728 - 1736. [Abstract] [Full Text]